ES135
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ES135, covering 2024-05-08 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Safety and Efficacy of ES135 in Subjects With Spinal Cord Injury [Phase 3]